Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

By WebmasterNovember 11, 2021November 1st, 2024No Comments

Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Previous PostData from ImmunoGenesis' Lead Programs Presented in Six Posters at Society for Immunotherapy of Cancer (SITC) Conference
Next PostBridge Bank Issues $4 Million Line of Credit to Ride Health